RespireRx Pharmaceuticals Inc (RSPI)

[neuroinv]

While I am sure they have talked to everyone, it's not as if that is a task that is ever finished. Other companies are always changing their priorities and licensing tactics, and the people executing these strategies are in flux as well. For example, I looked back at the 2011 purchasers of one of NIR's annual publications--who made that purchase between Dec 2010 and June 2011. To my surprise and dismay. half of them have been laid off by their companies. The downsizing in Pharma has been immense, which means small companies are always having to reintroduce themselves in the hope that the stars will line up at some point (that metaphor is not mine, it actually came from the head of BusDev for one of the largest pharma companies) between programs and motivations. So Jim Coleman is in the position of continually monitoring a landscape in perpetual change, and when someone with whom he thought he has a conversation underway leaves, he has to start over again.

NP